Cochlear | COH - Beneficio Bruto En Ventas

Precio De Mercado
94.00
Cambio Diario
4.00 4.44%
Mensual
-44.41%
Anual
-65.64%
Q2 Expectativa
95.52




Beneficio Bruto En Ventas Cambio Fecha
Ansell USD 326.2M 27.6M 2024-06
Avita Medical AUD 14.31M 639K 2025-12
Cochlear AUD 856.8M 430M 2025-12
CSL USD 4.46B 2.71B 2025-12
Fisher Paykel Healthcare NZD 685.7M 3.5M 2025-12
Healius AUD 554.4M 415.55M 2024-12
Integral Diagnostics AUD 226.91M 7.04M 2024-06
Mayne Pharma AUD 86.13M 18.92M 2025-06
Mesoblast USD 3.16M 9.61M 2024-12
Monash IVF AUD 110.44M 89.18M 2025-12
Nanosonics AUD 78.01M 3.95M 2025-12
Polynovo AUD 61.26M 38M 2025-12
Ramsay Health Care AUD 549.95M 5.77B 2025-06
Regis Healthcare AUD 47.9M 43.33M 2025-06
ResMed USD 886.53M 65.71M 2025-12
Sigma Healthcare AUD 160.13M 10.55M 2024-07
Somnomed AUD 26.76M 1.59M 2023-06
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Telix Pharmaceuticals AUD 217.82M 9.23M 2025-12